Trumenba

RSS

meningococcal group b vaccine (recombinant, adsorbed)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Trumenba. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Trumenba.

For practical information about using Trumenba, patients should read the package leaflet or contact their doctor or pharmacist.

This EPAR was last updated on 24/05/2022

Authorisation details

Product details
Name
Trumenba
Agency product number
EMEA/H/C/004051
Active substance
Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B
International non-proprietary name (INN) or common name
meningococcal group b vaccine (recombinant, adsorbed)
Therapeutic area (MeSH)
Meningitis, Meningococcal
Anatomical therapeutic chemical (ATC) code
J07AH09
Publication details
Marketing-authorisation holder
Pfizer Europe MA EEIG
Revision
12
Date of issue of marketing authorisation valid throughout the European Union
24/05/2017
Contact address

Boulevard de la Plaine 17
1050 Bruxelles
Belgium

Product information

25/04/2022 Trumenba - EMEA/H/C/004051 - R/0036

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Bacterial vaccines

  • Meningococcal vaccines

Therapeutic indication

Trumenba is indicated for active immunisation of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.

The use of this vaccine should be in accordance with official recommendations.

Assessment history

How useful was this page?

Add your rating
Average
1 rating
3 ratings